Grifols USA Inc (Los Angeles, Calif) recently launched the Gri-fill System 3.0 to help pharmacists improve the quality of compounded sterile preparations and the processes used to prepare them. The system represents advancement in automated compounding technology and a real advantage for pharmacists wanting a practical solution to the operational challenges they face today, including compliance with the United States Pharmacopeia Chapter 797 standards. The Gri-fill System 3.0 is a completely closed system. It automatically reconstitutes solutions and withdraws volumes in a completely controlled system. The product also delivers sterility. The system uses special containers that have 0.22-μm filters in the filling ports. This enables the product to filter each dose as it is prepared. Once the fill is complete, the system automatically tests each filter for integrity. The product also features traceability. The Gri-fill System 3.0 provides documentation of every step throughout the compounding process, including the quantities of each component and the filter integrity test result for each dose. For more information, visit www.grifols.com, or call 800-421-0008.
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.
Clinical features with downloadable PDFs